| Product NDC: | 0002-8799 |
| Proprietary Name: | Humalog |
| Non Proprietary Name: | Insulin lispro |
| Active Ingredient(s): | 100 [iU]/mL & nbsp; Insulin lispro |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0002-8799 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020563 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080116 |
| Package NDC: | 0002-8799-59 |
| Package Description: | 5 SYRINGE in 1 CARTON (0002-8799-59) > 3 mL in 1 SYRINGE (0002-8799-01) |
| NDC Code | 0002-8799-59 |
| Proprietary Name | Humalog |
| Package Description | 5 SYRINGE in 1 CARTON (0002-8799-59) > 3 mL in 1 SYRINGE (0002-8799-01) |
| Product NDC | 0002-8799 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Insulin lispro |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20080116 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | INSULIN LISPRO |
| Strength Number | 100 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |